Rankin Aubrey
President, Innovation & Tech at Revance Therapeutics, Inc.
- Sold, on record
- $8.7M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Aug 16, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.President, Innovation & Tech
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Revance Therapeutics, Inc.Plan not statedNov 30, 2020 2020
Sold 33,119 shares at $23.85 ($790k)
Rankin Aubrey, President, Innovation & Tech
Sold 6.1% of holdings ($13M position)510,684 shares leftFiling
- 2 Form 4 sale Revance Therapeutics, Inc.Plan not statedDec 30, 2020 +30 days
Sold 33,119 shares at $27.82 ($921k)
Rankin Aubrey, President, Innovation & Tech
Sold 6.5% of holdings ($14.2M position)477,565 shares left1x usual sizeFiling
- 3 Form 4 sale Revance Therapeutics, Inc.Plan not statedFeb 1, 2021 +33 days
Sold 33,119 shares at $25.95 ($859k)
Rankin Aubrey, President, Innovation & Tech
Sold 6.9% of holdings ($12.4M position)444,446 shares left1x usual sizeFiling
- 4 Form 4 sale Revance Therapeutics, Inc.Plan not statedMar 4, 2021 +31 days
Sold 33,119 shares at $25.43 ($842k)
Rankin Aubrey, President, Innovation & Tech
Sold 7.5% of holdings ($11.3M position)411,327 shares left1x usual sizeFiling
- 5 Form 4 sale Revance Therapeutics, Inc.Plan not statedApr 5, 2021 +32 days
Sold 2 shares at $28.28 ($57)
Rankin Aubrey, President, Innovation & Tech
Sold 0% of holdings ($11.6M position)411,325 shares left0x usual sizeFiling
- 6 Form 4 sale Revance Therapeutics, Inc.Plan not statedJul 26, 2021 +112 days
Sold 55,382 shares at $29.72 ($1.6M)
Rankin Aubrey, President, Innovation & Tech
Sold 13.5% of holdings ($12.2M position)355,943 shares left1.7x usual sizeFiling
- 7 Form 4 sale Revance Therapeutics, Inc.UnusualJul 28, 2021 +2 days
Sold 54,332 shares at $30.06 ($1.6M)
Rankin Aubrey, President, Innovation & Tech
Sold 26% of holdings ($6.3M position)154,302 shares left1.6x usual sizeFiling
- 8 Form 4 sale Revance Therapeutics, Inc.Plan not statedAug 16, 2021 +19 days
Sold 9,364 shares at $26.34 ($247k)
Rankin Aubrey, President, Innovation & Tech
Sold 12.5% of holdings ($2M position)65,463 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Aug 17, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 9,364 | $247k | 12.5% | Plan not stated | SEC |
| Jul 28, 2021 | Jul 30, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 54,332 | $1.6M | 26.0% | Unusual | SEC |
| Jul 26, 2021 | Jul 28, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 55,382 | $1.6M | 13.5% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 6, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 2 | $57 | 0.0% | Plan not stated | SEC |
| Mar 4, 2021 | Mar 5, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $842k | 7.5% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 3, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $859k | 6.9% | Plan not stated | SEC |
| Dec 30, 2020 | Jan 4, 2021 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $921k | 6.5% | Plan not stated | SEC |
| Nov 30, 2020 | Dec 2, 2020 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $790k | 6.1% | Plan not stated | SEC |
| Oct 29, 2020 | Oct 30, 2020 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $866k | 5.7% | Plan not stated | SEC |
| Sep 28, 2020 | Sep 30, 2020 | Revance Therapeutics, Inc. | President, Innovation & Tech | Form 4 sale | 33,119 | $867k | 5.4% | Plan not stated | SEC |